Prostate Cancer Coverage from Every Angle

Rana R. McKay, MD: Which Patients Might Benefit From Neoadjuvant Androgen Deprivation Before Radical Prostatectomy?

Posted: Monday, June 15, 2020

Rana R. McKay, MD, of the University of California, San Diego, reports the phase II study findings on intense neoadjuvant hormone therapy followed by radical prostatectomy in men with high-risk prostate cancer and discusses which patients might benefit from neoadjuvant androgen deprivation.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.